Cargando…

Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma

The gut microbiota is a well‐known prognostic factor and a modulator of treatment sensitivity in patients with cancers treated with immune checkpoint inhibitors. However, data on hepatocellular carcinoma (HCC) are lacking. This study aimed to evaluate the prognostic role of the gut microbiota and ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponziani, Francesca Romana, De Luca, Angela, Picca, Anna, Marzetti, Emanuele, Petito, Valentina, Del Chierico, Federica, Reddel, Sofia, Paroni Sterbini, Francesco, Sanguinetti, Maurizio, Putignani, Lorenza, Gasbarrini, Antonio, Pompili, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134810/ https://www.ncbi.nlm.nih.gov/pubmed/35261212 http://dx.doi.org/10.1002/hep4.1905

Ejemplares similares

High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis
por: Ponziani, Francesca Romana, et al.
Publicado: (2022)

Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study
por: Picca, Anna, et al.
Publicado: (2019)

The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions
por: Reddel, Sofia, et al.
Publicado: (2019)

Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota
por: Del Chierico, Federica, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives
por: Paratore, Mattia, et al.
Publicado: (2021)

Enteric Dysbiosis and Fecal Calprotectin Expression in Premature Infants
por: Ho, Thao T. B., et al.
Publicado: (2018)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
por: Graziani, Cristina, et al.
Publicado: (2022)

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Analysis of gut microbiota in patients with Williams–Beuren Syndrome reveals dysbiosis linked to clinical manifestations
por: Del Chierico, Federica, et al.
Publicado: (2023)

Gut Mucosal and Fecal Microbiota Profiling Combined to Intestinal Immune System in Neonates Affected by Intestinal Ischemic Injuries
por: Romani, Lorenza, et al.
Publicado: (2020)

Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
por: Cerreto, Maria, et al.
Publicado: (2021)

Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
por: Maestri, Marta, et al.
Publicado: (2023)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis
por: Petito, Valentina, et al.
Publicado: (2019)

Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations
por: Quagliariello, Andrea, et al.
Publicado: (2020)

Gut Microbiota Profiling and Gut–Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
por: Quagliariello, Andrea, et al.
Publicado: (2018)

Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
por: De Maio, Flavio, et al.
Publicado: (2020)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
por: Costante, Federico, et al.
Publicado: (2022)

Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis
por: Maccauro, Valeria, et al.
Publicado: (2023)

Longitudinal Multi-Omics Study of a Mother-Infant Dyad from Breastfeeding to Weaning: An Individualized Approach to Understand the Interactions Among Diet, Fecal Metabolome and Microbiota Composition
por: Conta, Giorgia, et al.
Publicado: (2021)

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
por: Cerrito, Lucia, et al.
Publicado: (2019)

Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection
por: Ponziani, Francesca Romana, et al.
Publicado: (2021)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
por: Ristori, Maria Vittoria, et al.
Publicado: (2019)

Fecal Calprotectin in Self-Reported Milk Intolerance: Not Only Lactose Intolerance
por: Seidita, Aurelio, et al.
Publicado: (2023)

Can fecal calprotectin better stratify Crohn’s disease activity index?
por: Scaioli, Eleonora, et al.
Publicado: (2015)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Impact of Two Antibiotic Therapies on Clinical Outcome and Gut Microbiota Profile in Liver Transplant Paediatric Candidates Colonized by Carbapenem-Resistant Klebsiella pneumoniae CR-KP
por: Cardile, Sabrina, et al.
Publicado: (2021)

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

Gut Microbiota Profile in Children with IgE-Mediated Cow’s Milk Allergy and Cow’s Milk Sensitization and Probiotic Intestinal Persistence Evaluation
por: Mennini, Maurizio, et al.
Publicado: (2021)

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
por: Ianiro, Gianluca, et al.
Publicado: (2022)

Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
por: Pallozzi, Maria, et al.
Publicado: (2022)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease
por: Fabi, Marianna, et al.
Publicado: (2022)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6aj0peckoeipfk1ojc0e9ormjh